Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
2026
Earnings, Q2 FY2026
Aug 4, 2026
Q2 2026 featured robust leasing, $63.3M revenue, and major capital market transactions.
Investor presentation
Aug 1, 2026
Diversified REIT leverages triple-net leases and life science investments for strong, sustained growth.
Earnings, Q1 FY2026
May 5, 2026
Revenue up 3.5% to $69M, AFFO steady, and portfolio stabilized amid regulatory tailwinds.
Investor presentation
May 4, 2026
Diversified REIT with robust growth, strong balance sheet, and expanding life sciences exposure.
Company presentation
Feb 8, 2026
Diversified REIT leverages triple-net leases and sector expertise for growth in cannabis and life sciences.